PLXGX
Price
$20.79
Change
-$0.00 (-0.00%)
Updated
Apr 18, 6:59 PM EST
RGAFX
Price
$68.09
Change
-$0.00 (-0.00%)
Updated
Apr 18, 6:59 PM EST
Ad is loading...

Compare predictions PLXGX vs RGAFX

Header iconPLXGX vs RGAFX Comparison
Open Charts PLXGX vs RGAFXBanner chart's image
Virtus KAR Capital Growth I
Price$20.79
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5
Price$68.09
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PLXGX vs RGAFX Comparison Chart

Loading...

VS
PLXGX vs. RGAFX commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLXGX is a Sell and RGAFX is a StrongSell.

FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 262B vs. PLXGX (599M). RGAFX pays higher dividends than PLXGX: RGAFX (0.73) vs PLXGX (0.00). PLXGX was incepted earlier than RGAFX: PLXGX (18 years) vs RGAFX (22 years). RGAFX is a more actively managed with annual turnover of: 31.00 vs. PLXGX (12.00). RGAFX has a lower initial minimum investment than PLXGX: RGAFX (250) vs PLXGX (100000). RGAFX (24.32) and PLXGX (23.97) have marching annual gain over last year. RGAFX return over 5 years is better than : 39.57 vs. PLXGX (20.18).
PLXGXRGAFXPLXGX / RGAFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years22 years-
Gain YTD7.9447.891101%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets599M262B0%
Annual Yield % from dividends0.000.73-
Returns for 1 year23.9724.3299%
Returns for 3 years-26.64-4.59580%
Returns for 5 years20.1839.5751%
Returns for 10 years135.0862.16217%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMI18.210.45
+2.53%
Kinder Morgan
CVLT94.15-0.48
-0.51%
Commvault Systems
NRDS13.26-0.09
-0.67%
NerdWallet
VYNE2.30-0.10
-4.17%
VYNE Therapeutics
ENTA13.23-0.77
-5.50%
Enanta Pharmaceuticals